High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors
- 17 May 1998
- journal article
- research article
- Published by Elsevier in Current Problems in Cancer
- Vol. 22 (3), 138-177
- https://doi.org/10.1016/s0147-0272(98)90005-8
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe?Journal of Clinical Oncology, 1997
- Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.Journal of Clinical Oncology, 1997
- Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.Journal of Clinical Oncology, 1997
- Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftmentBone Marrow Transplantation, 1997
- High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerBone Marrow Transplantation, 1997
- High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.Journal of Clinical Oncology, 1997
- Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analysesBone Marrow Transplantation, 1997
- The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancerCA: A Cancer Journal for Clinicians, 1996
- High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.Journal of Clinical Oncology, 1992
- High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.Journal of Clinical Oncology, 1988